<DOC>
	<DOCNO>NCT00212381</DOCNO>
	<brief_summary>To determine use oral Diindolylmethante ( DIM ) , market cruciferous vegetable base dietary supplement ( Bioresponse-DIM ) , associate regression cervical dysplasia otherwise healthy woman .</brief_summary>
	<brief_title>Oral Diindolylmethane ( DIM ) Treatment Cervical Dysplasia</brief_title>
	<detailed_description>To determine use oral Diindolylmethane ( DIM ) , market cruciferous vegetable base dietary supplement ( BioResponse-DIMÂ® ) , associate regression cervical dysplasia otherwise healthy woman . Additionally , study aim see use BioResponse-DIM supplement correlate cervical HPV colonization , asses tolerability daily DIM supplementation</detailed_description>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<criteria>Non pregnant woman great equal 18 year age able consent CIN II III confirm histology Karnofsky performance status &gt; = 80 No prior treatment dysplasia past 4 month Incompletely visible lesion Diethylstilbestrol ( DES ) exposure HIV seropositive</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>cervical dysplasia , diindolylmethane , pap smear</keyword>
</DOC>